Neuroendocrine tumor (NET) disease is both rare and complex. About 15,000 new patients are diagnosed each year in the U.S. – which means many medical professionals will encounter neuroendocrine tumors only a few times in their careers.

The North American Neuroendocrine Tumor Society (NANETS) is a society of over 500 multidisciplinary medical professionals committed to the support of colleagues in diagnosing and treating NET patients, as well as furthering the cause of NET science and education in North America. With new research, technologies and practices emerging, the landscape of NET treatment is rapidly changing.

We invite you to the 2020 Multidisciplinary NET Medical Virtual Symposium (Oct. 2-3), Allied Health Seminar (Sept. 11), Early Career Seminar (Sept. 18) and the Future of NETs presentation (Dec. 10). In addition to continuing education accredited sessions, gain from cutting-edge NET research in interactive sessions and poster session, and young investigator presentations. NANETS' annual grant awards will be announced during The Future of NETs presentation. Learn more about submitting for NANETS annual grant awards.